Fixed-Dose Combination Therapy with Statins: Strengths, Limitations, and Clinical and Regulatory Considerations

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.8, Iss.3, 2008-01, pp. : 155-160

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

WHO endorses fixed-dose triple combination HIV therapy

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 438, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Fixed-dose combination of abacavir, lamivudine and zidovudine for HIV therapy

By Milinkovic Ana Mallolas Josep

Future Virology, Vol. 2, Iss. 1, 2007-01 ,pp. : 23-30

Future Medicine

Access to resources Recommend Favorite

Fixed-dose combination therapy for type 2 diabetes: sitagliptin plus pioglitazone

By Bailey Clifford J Green Brian D Flatt Peter R

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 8, 2010-08 ,pp. : 1017-1025

Informa Healthcare

Access to resources Recommend Favorite

Fixed-Dose Combination Lercanidipine/Enalapril

By Hair Philip I. Scott Lesley J. Perry Caroline M.

Drugs, Vol. 67, Iss. 1, 2007-01 ,pp. : 95-106

Adis International

Access to resources Recommend Favorite

Compliance with Antihypertensive Therapy in the Elderly: A Comparison of Fixed-Dose Combination Amlodipine/Benazepril versus Component-Based Free-Combination Therapy

By Dickson Michael

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 1, 2008-01 ,pp. : 45-50

Adis International

Access to resources Recommend Favorite